J&J’s Sales and Profit Rise on Strong Cancer and Autoimmune Drug Sales
- Posted on January 21, 2026
- By The Wall Street Journal
- 3 Views
J&J’s Sales and Profit Rise on Strong Cancer and Autoimmune Drug Sales
The healthcare company’s forecast for 2026 tops Wall Street’s expectations.
